Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D
Lucid Diligence Brief: Angitia Biopharmaceuticals $130 million Series D…
Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen
Lucid Diligence Brief: Kyowa Kirin regains rocatinlimab rights from Amgen…
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled…
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized CRISPR
Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized…
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m Professional…
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled clinical-trial recruitment
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled…
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG
Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG Professional…